Kinloch Capital LLC Has $1.76 Million Stock Position in The Clorox Company $CLX

Kinloch Capital LLC lowered its holdings in shares of The Clorox Company (NYSE:CLX) by 31.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 17,483 shares of the company’s stock after selling 7,956 shares during the quarter. Kinloch Capital LLC’s holdings in Clorox were worth $1,763,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Vermillion & White Wealth Management Group LLC bought a new position in Clorox during the third quarter valued at about $25,000. Caitlin John LLC raised its stake in shares of Clorox by 1,807.1% in the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after acquiring an additional 253 shares in the last quarter. Darwin Wealth Management LLC acquired a new stake in Clorox in the 2nd quarter worth approximately $29,000. Vision Financial Markets LLC boosted its position in Clorox by 166.7% during the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares during the period. Finally, Ameriflex Group Inc. grew its holdings in Clorox by 1,436.8% during the third quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after purchasing an additional 273 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

CLX has been the subject of several recent analyst reports. Evercore reaffirmed an “underperform” rating and set a $110.00 price objective on shares of Clorox in a report on Friday, May 1st. Weiss Ratings raised shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. BNP Paribas Exane lowered their price target on Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 12th. UBS Group dropped their price objective on Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $91.00 target price on shares of Clorox in a research note on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Reduce” and a consensus price target of $103.40.

Clorox Stock Up 1.0%

CLX stock opened at $95.90 on Friday. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $132.03. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The company has a market cap of $11.60 billion, a PE ratio of 15.57, a price-to-earnings-growth ratio of 0.49 and a beta of 0.56. The business’s 50-day simple moving average is $95.91 and its 200 day simple moving average is $104.88.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the prior year, the firm posted $1.45 EPS. The company’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, research analysts anticipate that The Clorox Company will post 5.61 earnings per share for the current year.

Insiders Place Their Bets

In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of the stock in a transaction on Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, with a total value of $429,100.00. Following the acquisition, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. This represents a 38.46% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.63% of the stock is owned by corporate insiders.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.